Literature DB >> 25093971

C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study.

Ruud G Nijman1, Henriëtte A Moll, Frank J Smit, Alain Gervaix, Floor Weerkamp, Yvonne Vergouwe, Yolanda B de Rijke, Rianne Oostenbrink.   

Abstract

BACKGROUND: C-reactive protein (CRP) and procalcitonin (PCT) are useful diagnostic tools to estimate the risk of serious bacterial infection (SBI) in febrile children at the emergency department (ED). The Lab-score combines these 2 biomarkers with urinalysis in an easy to use validated model. Kinetics of inflammatory markers suggests a differentiating role of duration of disease. AIM: : Appraisal of the diagnostic role of CRP and PCT in febrile children at risk of SBI, determining the differentiating value of duration of fever, and validating and updating the Lab-score.
METHODS: In this prospective observational study previously healthy children with fever, 1 month to 16 years of age, attending the EDs of a university hospital and a teaching hospital (Rotterdam, the Netherlands) between 2009 and 2012 were included. Standardized information on clinical signs and symptoms, CRP, PCT and urinalysis were collected prospectively. Logistic multivariable regression analysis was used to assess diagnostic performance. The original Lab-score included CRP, PCT and urinalysis and the total score ranged 0-9 points.
RESULTS: One thousand eighty-four children were included, median age was 1.6 years (interquartile range: 0.8-3.5), 170 children (16%) had SBI. CRP [receiver operating characteristic (ROC)-area 0.77 (95% confidence interval [CI]: 0.69-0.85)] and PCT [ROC-area 0.75 (95% CI: 0.67-0.83)] were both strong predictors of SBI. Duration of fever had no added diagnostic value to CRP and PCT. The Lab-score performed well [ROC area 0.79 (95% CI: 0.72-0.87)], but threshold values performed similar to often used cutoffs of single biomarkers. An updated Lab-score improved only moderately [ROC area 0.83 (95% CI: 0.76-0.90)]. PCT did not alter post-test probabilities for SBI substantially in patients with low (<20 mg/L) or elevated CRP (≥ 100 mg/L) levels (67% of population).
CONCLUSION: CRP and PCT were both strong predictors of SBI. The original and updated Lab-score performed well, but thresholds values lacked diagnostic value for ruling out SBI. Depending on clinical risk thresholds, diagnostic testing can be limited to CRP or PCT, rather than both, in many febrile children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25093971     DOI: 10.1097/INF.0000000000000466

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

1.  Evaluation of the bedside Quikread go® CRP test in the management of febrile infants at the emergency department.

Authors:  S Hernández-Bou; V Trenchs; M I Vanegas; A F Valls; C Luaces
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-03       Impact factor: 3.267

2.  Validation of the Feverkidstool and procalcitonin for detecting serious bacterial infections in febrile children.

Authors:  Ruud G Nijman; Yvonne Vergouwe; Henriëtte A Moll; Frank J Smit; Floor Weerkamp; Ewout W Steyerberg; Johan van der Lei; Yolanda B de Rijke; Rianne Oostenbrink
Journal:  Pediatr Res       Date:  2017-11-08       Impact factor: 3.756

3.  Use of procalcitonin and C-reactive protein in the diagnosis of bacterial infection in infants with severe bronchiolitis.

Authors:  Carme Alejandre; Carmina Guitart; Mònica Balaguer; Isabel Torrús; Sara Bobillo-Perez; Francisco José Cambra; Iolanda Jordan
Journal:  Eur J Pediatr       Date:  2020-09-14       Impact factor: 3.183

4.  Accuracy of Complete Blood Cell Counts to Identify Febrile Infants 60 Days or Younger With Invasive Bacterial Infections.

Authors:  Andrea T Cruz; Prashant Mahajan; Bema K Bonsu; Jonathan E Bennett; Deborah A Levine; Elizabeth R Alpern; Lise E Nigrovic; Shireen M Atabaki; Daniel M Cohen; John M VanBuren; Octavio Ramilo; Nathan Kuppermann
Journal:  JAMA Pediatr       Date:  2017-11-06       Impact factor: 16.193

5.  Predicting Outcome of Childhood Bacterial Meningitis With a Single Measurement of C-Reactive Protein.

Authors:  Heikki Peltola; Tuula Pelkonen; Irmeli Roine; Manuel Leite Cruzeiro; Luis Bernardino
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

6.  Profile of C-reactive protein, white cells and neutrophil populations in febrile children from rural north-eastern Tanzania.

Authors:  Coline Mahende; Billy Ngasala; John Lusingu; Thomas Mårtensson; Paminus Lushino; Martha Lemnge; Bruno Mmbando; Zul Premji
Journal:  Pan Afr Med J       Date:  2017-01-31

7.  A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational study.

Authors:  Liat Ashkenazi-Hoffnung; Kfir Oved; Roy Navon; Tom Friedman; Olga Boico; Meital Paz; Gali Kronenfeld; Liat Etshtein; Asi Cohen; Tanya M Gottlieb; Eran Eden; Irina Chistyakov; Isaac Srugo; Adi Klein; Shai Ashkenazi; Oded Scheuerman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-26       Impact factor: 3.267

8.  Low Bacterial Co-infection Invalidates the Early Use of Non-anti-Mycoplasma pneumoniae Antibiotics in Pediatric Refractory Mycoplasma pneumoniae Pneumonia Patients.

Authors:  Jin-Rong Liu; Jie Lu; Fang Dong; Hui-Min Li; Hui Liu; Xiao-Lei Tang; Yong-Li Guo; Shun-Ying Zhao
Journal:  Front Pediatr       Date:  2018-10-26       Impact factor: 3.418

9.  The Value of the "Lab-Score" Method in Identifying Febrile Infants at Risk for Serious Bacterial Infections.

Authors:  Diana Aniela Moldovan; Maria Despina Baghiu; Alina Balas; Sorana Teodora Truta
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-03-01

10.  Assessment of Immature Granulocytes Percentage to Predict Severe Bacterial Infection in Latvian Children: An Analysis of Secondary Data.

Authors:  Jana Pavare; Ilze Grope; Dace Gardovska
Journal:  Medicina (Kaunas)       Date:  2018-08-10       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.